Human Colorectal Cancer (CRC) Antigen CO17-1A/GA733 Encoded by Adenovirus Inhibits Growth of Established CRC Cells in Mice

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 763-769

  Li, Weiping ^a   Berencsi, Klara ^a   Basak, Saroj ^a   Somasundaram, Rajasekharan ^a   Ricciardi, Robert P ^a   Gönczöl, Eva ^a   Zaloudik, Jan ^a   Linnenbach, Alban ^a   Maruyama, Haruhiko ^a   Miniou, Pierre ^a   Herlyn, Dorothee ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOMA-ASSOCIATED ANTIGEN 17-1A; EPITHELIAL CELL ADHESION MOLECULE; TUMOR ANTIGEN; VIRUS ANTIGEN;

ADENOVIRUS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CARCINOMA; CELL DIVISION; COLORECTAL TUMOR; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MOUSE; PATHOLOGY;

ADENOVIRIDAE; ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; CARCINOMA; CELL DIVISION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL;

EID: 0031570949     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Herlyn, M., Z. Steplewski, D. Herlyn, and H. Koprowski. 1979. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc. Natl. Acad. Sci. USA 76:1438.
2. Herlyn, D., M. Herlyn, A. H. Ross, C. Ernst, B. Atkinson, and H. Koprowski. 1984. Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J. Immunol. Methods 73:157.
3. Ross, A. H., D. Herlyn, D. Iliopoulos, and H. Koprowski. 1986. Isolation and characterization of a carcinoma-associated antigen. Biochem. Biophys. Res. Commun. 135:297.
4. Göttlinger, H. G., I. Funke, J. P. Johnson, J. M. Gokel, and G. Riethmüller. 1986. The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int. J. Cancer 38:47.
5. Herlyn, M., Z. Steplewski, D. Herlyn, and H. Koprowski. 1986. CO17-1A and related monoclonal antibodies: their production and characterization. Hybridoma 5(Suppl. 1):S3.
6. Shetye, J., J.-E. Frödin, B. Christensson, C. Grant, B. Jacobsson, S. Sundelius, M. Sylvén, P. Biberfeld, and H. Mellstedt. 1988. Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (mAb 17-1A). Cancer Immunol. Immunother. 27:154.
7. Shetye, J., B. Christensson, C. Rubio, M. Rodensjö, P. Biberfeld, and H. Mellstedt. 1989. The tumor-associated antigens BR55-2, GA73-3, and GICA 19-9 in normal and corresponding neoplastic human tissues, especially gastrointestinal tissues. Anticancer Res. 9:395.
8. Sears, H. F., D. Herlyn, M. Herlyn, P. J. Grotzinger, Z., Steplewski, and H. Koprowski. 1981. Ex vivo perfusion of a tumor-containing colon with monoclonal antibody. J. Surg. Res. 31:145.
9. Sears, H. F., D. Herlyn, M. Herlyn, Z. Steplewski, P. Grotzinger, and H. Koprowski. 1982. Ex vivo perfusion of human colon with monoclonal anti-colorectal cancer antibodies. Cancer 49:1231.
10. Mach, J.-P., J.-F. Chatal, J.-D. Lumbroso, F. Buchegger, M. Forni, J. Ritschard, C. Berche, J.-Y. Douillard, S. Carrel, M. Herlyn, Z. Steplewski, and H. Koprowski. 1983. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res. 43:5593.
11. Powe, J., D. Herlyn, A. Alavi, D. Munz, Z. Steplewski, and H. Koprowski. 1985. Radioimmunodetection of human tumor xenografts by monoclonal antibodies correlates with antibody density and affinity. In Immunoscintigraphy. K. Button and L. Donato, eds. Gordon and Breach Science Publishers, New York, p. 135.
12. LoBuglio, A. F., M. N. Saleh, J. Lee, M. B. Khazaeli, R. Carrano, H. Holden, and R. Wheeler. 1988. Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspects. J. Natl. Cancer Inst. 80:932.
13. Riethmüller, G., E. Schneider-Gädicke, G. Schlimok, W. Schmiegel, R. Raab, K. Höffken, R. Gruber, H. Pichlmaier, H. Hirche, R. Pichlmayr, P. Buggisch, J. Witte, and German Cancer Aid 17-1A Study Group. 1994. Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 343:1177.
14. Herlyn, D., M. Wettendorff, E. Schmoll, D. Illiopoulos, I. Schedel, U. Dreikhausen, R. Raab, A. H. Ross, H. Jaksche, M. Scriba, and H. Koprowski, 1987. Anti-idiotype immunization of cancer patients: modulation of the immune response. Proc. Natl. Acad. Sci. USA 84:8055.
15. Loibner, H., R. Plot, A. Rot, G. Werner, M. Wrann, H. Samonigg, M. Schmid, H. Stoger, M. Truschnig, D. Herlyn, and H. Koprowski. 1990. Immunoreactivity of patient with colorectal cancer metastasis after immunization with anti-idiotypes. Lancet 335:171.
16. Herlyn, D., A. Benden, M. Kane, R. Somasundaram, J. Zaloudik, M. Sperlagh, G. Marks, E. Hart, C. Ralph, M. Wettendorff, and M. Mastrangelo. 1991. Anti-idiotype cancer vaccines: preclinical and clinical studies. In Vivo 5:615.
17. Herlyn, D., D. Harris, J. Zaloudik, M. Sperlagh, H. Maruyama, L. Jacob, M.-P. Kieny, S. Scheck, R. Somasundaram, E. Hart, H. Ertl, and M. Mastrangelo. 1994. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients. J. Immunother. 15:303.
18. Somasundaram, R., J. Zaloudik, L. Jacob, A. Benden, M. Sperlagh, E. Hart, G. Marks, M. Kane, M. Mastrangelo, and D. Herlyn. 1995. Induction of T- and B-cell immunity in colon carcinoma patients by anti-idiotypic antibody. J. Immunol. 155:3253.
19. Maruyama, H., A. Benden, W. Li, J. Zaloudik, T. Koido, J.-L. Taupin, B. Acres, R. Somasundaram, M. Prewett, and D. Herlyn. 1996. Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733. Int. J. Cancer 65:547.
20. Wettendorff, M., D. Illiopoulos, M. Tempero, D. Kay, E. DeFreitas, H. Koprowski, and D. Herlyn. 1989. Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A. Proc. Natl. Acad. Sci. USA 86:3787.
21. Zhai, Y., J. C. Yang, Y. Kawakami, P. Spiess, S. C. Wadsworth, L. M. Cardoza, L. A. Couture, A. E. Smith, and S. A. Rosenberg. 1996. Antigen-specific tumor vaccines. J. Immunol. 156:700.
22. Houghton, A. N. 1995. On course for a cancer vaccine. Lancet 345:1384.
23. Townsend, A. R. M., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The cpitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined wilh short synthetic peptides. Cell 44:959.
24. Bergsagel, P. L., C. Victor-Kobrin, C. R. Timblin, J. Trepel, and W. M. Kuehl. 1992. A murine cDNA encodes a pan-epithelial glycoprotcin that is also expressed on plasma cells. J. Immunol. 148:590.
25. Basak, S., J. Zaloudik, M. Nesbit, W. Wunner, S. Eck, P. L. Bergsagel, and D. Herlyn. 1996. Mouse model of active immunotherapy against the human colon carcinoma-associated antigen CO17-1A/GA733. Proc. Am. Assoc. Cancer Res. 37:445 (Abstr.).
26. Herlyn, M., G. Balaban, J. Bennicelli, D. Guerry IV, R. Halaban, D. Herlyn, D. E. Elder, G. G. Maul, Z. Steplewski, P. C. Nowell, W. H. Clark, and H. Koprowski. 1985. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J. Natl. Cancer Inst. 74:283.
27. Giard, D. J., S. A. Aaronson, G. J. Todaro, P. Arnstein, J. H. Kersey, H. Dosik, and W. P. Parks. 1973. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51:1417.
28. Koprowski, H., Z. Steplewski, K. Mitchell, M. Herlyn, D. Herlyn, and P. Fuhrer. 1979. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 5:957.
29. Strassburg, C. P., Y. Kasai, B. A. Seng, J. Zaloudik, D. Herlyn, H. Koprowski, and A. J. Linnenbach. 1992. Baculovirus recombinant expressing a secreted form of a trans-membrane carcinoma-associated antigen. Cancer Res. 52:815.
30. Berencsi, K., R. F. Rando, C. deTaisne, E. Paoletti, S. A. Plotkin, and E. Gönczöl. 1993. Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced hy adenovirus and vaccinia virus recombinants expressing gB. J. Gen. Virol. 74:2507.
31. Marshall, G. S., R. P. Ricciardi, R. Rando, J. Puck, R. Ge, S. A. Plotkin, and E. Gönczöl. 1990. An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies. J. Infect. Dis. 162:1177.
32. Szala, S., M. Froehlich, M. Scollon, Y. Kasai, Z. Steplewski, H. Koprowski, and A. J. Linnenbach. 1990. Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc. Natl. Acad Sci. USA 87:3542.
33. Herlyn, D., and H. Koprowski. 1982. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc. Natl. Acad. Sci. USA 79:4761.
34. Celluzzi, C. M., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and L. D. Falo, Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
35. Falo, L. D., Jr., M. Kovacsovics-Bankowski, K. Thompson, and K. L. Rock. 1995. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat. Med. 1:649.
36. Finkelman, F. D., I. M. Katona, T. R. Mosmann, and R. L. Coffman. 1988. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140:1022.
37. Ragot, T., S. Finerty, P. H. Watkins, M. Perricaudet, and A. J. Morgan. 1993. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. J. Gen. Virol. 74:501.
38. Chen, P. W., M. Wang, V. Bronte, Y. Zhai, S. A. Rosenberg, and N. P. Restifo. 1996. Therapeutic anti-tumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J. Immunol. 156:224.
39. Cooney, E. L., A. C. Collier, P. D. Greenberg, R. W. Coombs, J. Zarling, D. E. Arditti, M. C. Hoffman, S.-L. Hu, and L. Corey. 1991. Safety of an immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 337:567.
40. Tacket, C. O., G. Losonsky, M. D. Lubeck, A. R. Davis, S. Mizutani, G. Horwith, P. Hung, R. Edelman, and M. M. Levine. 1992. Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine. Vaccine 10:673.